Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Hormone Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03826160
What this trial is testing

Growth Hormone Dynamics and Cardiac Steatosis in HIV

Who this might be right for
Human Immunodeficiency VirusLipodystrophyCardiac Disease
Massachusetts General Hospital 23
Large-scale testing (Phase 3)Active Not RecruitingNCT03725059
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

Who this might be right for
Breast Cancer
Merck Sharp & Dohme LLC 1,240
Not applicableStudy completedNCT02152124
What this trial is testing

Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?

Who this might be right for
Acromegaly
University Hospital, Ghent 21
Not applicableEnded earlyNCT00145704
What this trial is testing

Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density

Who this might be right for
Osteopenia
State University of New York - Upstate Medical University 6
Testing effectiveness (Phase 2)Study completedNCT05250063
What this trial is testing

Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)

Who this might be right for
Growth Hormone Deficiency
Lumos Pharma 15
Testing effectiveness (Phase 2)Study completedNCT03272477
What this trial is testing

Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients

Who this might be right for
Breast Neoplasms
Palleos Healthcare GmbH 257
Testing effectiveness (Phase 2)Study completedNCT03288103
What this trial is testing

Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency

Who this might be right for
Short Stature
Children's Hospital Medical Center, Cincinnati 22
Post-approval studies (Phase 4)Study completedNCT00145340
What this trial is testing

Pioglitazone Treatment in Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Odense University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02668666
What this trial is testing

Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer

Who this might be right for
Hormone Receptor Positive Malignant Neoplasm of BreastHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastEstrogen Receptor Positive Breast Cancer+2 more
Oana Danciu, MD 49
Post-approval studies (Phase 4)UnknownNCT00145353
What this trial is testing

Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose

Who this might be right for
Type 1 Diabetes Mellitus
Odense University Hospital 16
Not applicableStudy completedNCT04916509
What this trial is testing

Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region

Who this might be right for
Breast Neoplasms
Pfizer 258
Large-scale testing (Phase 3)Study completedNCT00184717
What this trial is testing

Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)

Who this might be right for
Foetal Growth ProblemSmall for Gestational Age
Novo Nordisk A/S 98
Large-scale testing (Phase 3)Study completedNCT00184678
What this trial is testing

Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency

Who this might be right for
Growth Hormone DisorderAdult Growth Hormone Deficiency
Novo Nordisk A/S 161
Testing effectiveness (Phase 2)Active Not RecruitingNCT06105632
What this trial is testing

Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

Who this might be right for
Advanced or Metastatic Breast Cancer
Pfizer 333
Testing effectiveness (Phase 2)Ended earlyNCT07037420
What this trial is testing

ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly

Who this might be right for
Acromegaly
Alexion Pharmaceuticals, Inc. 8
Not applicableStudy completedNCT00568568
What this trial is testing

Metabolic Studies- Interactions Between GH and Insulin in GHDA

Who this might be right for
Insulin Resistance
University of Aarhus 8
Testing effectiveness (Phase 2)Looking for participantsNCT04121780
What this trial is testing

Growth Hormone Replacement Therapy for Retried Professional Football Players

Who this might be right for
TBI (Traumatic Brain Injury)Concussion, BrainSport Injury+3 more
Center for Neurological Studies 42
Large-scale testing (Phase 3)Study completedNCT04420481
What this trial is testing

Growth Hormone in Ischemic Heart Failure

Who this might be right for
Heart Failure, SystolicIschemic Heart Disease Chronic
Göteborg University 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT05558722
What this trial is testing

Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer

Who this might be right for
Breast Cancer Stage II
Xijing Hospital 31
Not applicableStudy completedNCT00420654
What this trial is testing

Growth Hormone Treatment of Women With Turner Syndrome

Who this might be right for
Turner Syndrome
Britta E. Hjerrild 24
Next Page